OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
about
Immunostimulants for preventing respiratory tract infection in childrenPidotimod: the past and the presentOM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells.Respiratory viral infections in children with asthma: do they matter and can we prevent them?Maintenance of immunological homeostasis by Indukantha ghritha in patients with recurrent upper respiratory tract infections-a pilot study.Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract.Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiencyAdjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom.Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art.OM-85 is an immunomodulator of interferon-β production and inflammasome activity.Protracted bacterial bronchitis: The last decade and the road ahead.Strategies to alter the natural history of childhood asthma.The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.Protection against maternal infection-associated fetal growth restriction: proof-of-concept with a microbial-derived immunomodulator.Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.The Calculated Risk of Childhood Asthma From Severe Bronchiolitis.Retrospective observational study to investigate Sinerga, a multifactorial nutritional product, and bacterial extracts in the prevention of recurrent respiratory infections in children.Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP.Childhood Asthma: Is It All About Bacteria and Not About Viruses? A Pro/Con Debate.The role of the microbiome in childhood asthma.Health-related quality of life in children and adolescents with congenital diaphragmatic hernia: a cross-sectional study.Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
P2860
Q24243914-2F8B35AC-8AAA-49D6-AC96-DF5A7FBB1F6BQ30356522-36F3AEB1-985A-4D4F-AB05-C494EAD6F3D7Q33842318-FF74CAB7-22AC-4C6E-878F-4CEB391D7047Q34413913-94063938-3676-4F9F-B6EA-74FA2FE8EC32Q34414168-E2130EF1-995E-4AEB-B8AF-23D7A74D327AQ34930189-C128D97C-EBAC-47DB-BAA7-ED88FE4DF18FQ35131041-278E20A4-D898-4B4E-A76E-008D7701DED9Q36319745-A695DD16-5D11-4F69-8866-721A64F45571Q36849789-9D2251EA-4315-46D0-AD33-E251165254BBQ36921486-F7B3F29B-3720-497D-B52A-A1B4E08E1FDBQ37682178-613D9EB8-8BDC-4FC8-AF8A-4525186D841BQ38659086-57C86B3D-9AFF-40E2-A8DF-7E328C8CBFB0Q39082639-C5DDD668-75AA-4369-88DA-391463827E87Q40214340-9E26A2B2-B995-4B5C-93FB-02EE8F5F1FC5Q40498590-B32C2E01-1D04-48C6-AB88-2C43D74CE851Q40697828-24908CBC-F7B5-42D5-AE80-DC34906BE814Q42350958-704044B8-D84C-4289-9E18-5F4298D225FCQ43891188-BA548F17-F052-4673-A3E7-2157DC5F7C98Q47137550-DB3D4CB1-34F1-46C7-9DC7-E152C91E4A41Q47552880-7B2681C0-CCBB-4944-BB38-E67C797958C9Q47713983-7B2D37BF-C790-4147-B2EA-37F0DCA9DBE4Q52655622-64BE5C9C-F4C4-4FD5-B4E3-3A32BF1C312DQ58694823-B956FF43-FAF2-4BED-820D-6097D777480C
P2860
OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@en
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@nl
type
label
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@en
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@nl
prefLabel
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@en
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@nl
P1476
OM-85 BV, an immunostimulant i ...... fections: a systematic review.
@en
P2093
Urs B Schaad
P2888
P356
10.1007/S12519-010-0001-X
P577
2010-02-09T00:00:00Z